Pharmacological aspects of the treatment of leukaemia in childhood

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorD'mello, Aarshia Vazirani
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Aneszteziológiai és Intenzív Terápiás Tanszékhu_HU
dc.date.accessioned2022-08-18T08:30:14Z
dc.date.available2022-08-18T08:30:14Z
dc.date.created2022-05-20
dc.description.abstractLeukaemia is the most common malignancy in childhood, with ALL being the most common subtype. However, in its entirety, leukaemia is a rare disease in childhood. Increasing number of risk factors, increase the likelihood of developing the disease and decreases the chances of a good prognosis. Diagnosis is mainly dependent on bone marrow biopsy, blood sampling and immunophenotyping, with symptoms only being complimentary. Treatment of such cancers involve both systemic chemotherapy and different targeted therapies. Fortunately with newer medical technology and research, more effective therapies are being tested and approved. Furthermore, combinations of both new and older models greatly improve the percentage of complete remission from leukaemia.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent43hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336568
dc.language.isoenhu_HU
dc.subjectChildhood leukaemiahu_HU
dc.subjectALLhu_HU
dc.subjectAMLhu_HU
dc.subjectCMLhu_HU
dc.subjectImmunotherapyhu_HU
dc.subjectChemotherapyhu_HU
dc.subjectTyrosine Kinase Inhibitorshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePharmacological aspects of the treatment of leukaemia in childhoodhu_HU
Fájlok